Supplemental information for PAR-16-357
What We Do:
The NIDA Genetics Consortium was created in 1999 and has several overarching missions:
- Identify human chromosomal regions containing genes and/or specific genes that confer susceptibility to drug addiction
- Create a repository for data (i.e., clinical information and biospecimens containing DNA) that are contributed by multiple studies, so as to permit pooling of data to maximize statistical power
- Generate a database on molecular genetics of drug use disorders and related phenotypes to provide controlled access for collaborative studies with the broader scientific community
- Establish a consortium of scientists who meet regularly and collaborate on projects
NIDA has created a list of domains and their associated measures to help with the harmonization of data in the area of genetic studies.
- Genetics Data Harmonization
- NIDA Center For Genetic Studies (cell and DNA biorepository)
- Description of Studies in the NIDA Genetics Consortium
Policies for access and distribution of DNA and clinical data from NIDA-funded studies on the genetics of addiction vulnerability
- Distribution of genetic data and biomaterials from the NIDA Center for Genetic Studies
- NIDA Distribution Agreement
- FAQs Related to the NIDA Genetic Studies, and Data and Biospecimen Submission and Access Through NIDA and NIH Resources
Any questions or concerns regarding the Human Genetics Consortium please contact Joni Rutter Ph.D.